Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein

While new direct-acting antiviral agents for the treatment of chronic hepatitis C virus (HCV) infection have been approved, there is a continued need for novel antiviral agents that act on new targets and can be used in combination with current therapies to enhance efficacy and to restrict the emerg...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Gu, Zhengxian, Graci, Jason D., Lahser, Frederick C., Breslin, Jamie J., Jung, Stephen P., Crona, James H., McMonagle, Patricia, Xia, Ellen, Liu, Shaotang, Karp, Gary, Zhu, Jin, Huang, Song, Nomeir, Amin, Weetall, Marla, Almstead, Neil G., Peltz, Stuart W., Tong, Xiao, Ralston, Robert, Colacino, Joseph M.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2013
נושאים:
Antiviral Agents
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3697315/
https://ncbi.nlm.nih.gov/pubmed/23629699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00527-13
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים